By NewsDesk @bactiman63
The Ministry of Health announced Friday an additional 1,132 COVID-19 cases, bringing the country total to 150,947 confirmed cases.
Of this total, 112,622 people have recovered and 1,895 deaths have been recorded.
On Friday, Representatives of the Ministry of Health, the Costa Rican Social Security Fund and the National Emergency Commission recapitulated the progress of the country on the way to launch the vaccination campaign against COVID-19.
“Costa Rica is acquiring high quality vaccines in terms of safety and efficacy, previously approved by strict regulatory agencies of the highest level of rigor worldwide,” Vice Minister of Health, Pedro González said.
Dr. González said to date, the Government of the Republic has signed three agreements for the purchase of vaccine: Pfizer-BioNTech (three million doses), AstraZeneca-Oxford (one million doses) and the COVAX initiative of the World Health Organization (two million doses).
These six million doses, which are purchased through the National Emergency Commission, will protect three million people against SARS-CoV-2 (two doses per person).
According to the bilateral agreements, the vaccines will begin to enter the country in the first quarter of next year. There is still no exact date for the delivery of the vaccines to the country.
The health authorities explained that the six million doses that the country is acquiring will not arrive at the same time, so the vaccination will be deferred in the different months throughout the year 2021.
- Nevada: Gonorrhea case with mosaic penA60 allele identified, First in the US
- Yellow fever: More monkey deaths in Paraná state
- Canada: COVID-19 outbreak at a mink farm in the Fraser Valley, British Columbia
- Europe: More than 500 avian influenza detections, Most in Germany
- India: Plasmodium ovale malaria reported in Kerala, Found in soldier returning from Africa
- Canada approves Pfizer COVID-19 vaccine
- Universal influenza virus vaccine: Strong and durable results in early-stage clinical trials in humans
- Zika virus: Virginia Tech researchers receives $2M grant to develop vaccine